中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    BEYFORTUS (nirsevimab-alip) injection
    BEYFORTUS (nirsevimab-alip) injection
    departments：感染科
    drug：注射剂
    Active：NIRSEVIMAB-ALIP
    indication：用于保护新生儿和婴儿免受RSV引起的下呼吸道疾病（LRTD）的侵害
    Licensor：AstraZeneca Pharmaceuticals LP
    Approved Country/Region：美国
    Approval time：2023-07-17